Viewray (NASDAQ:VRAY) posted its quarterly earnings data on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.23) by $0.06, Briefing.com reports. The firm had revenue of $20.66 million for the quarter, compared to the consensus estimate of $20.38 million. Viewray had a negative return on equity of 105.63% and a negative net margin of 105.09%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.38) EPS. Viewray updated its FY 2019 guidance to EPS.
NASDAQ:VRAY opened at $8.33 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 5.56 and a current ratio of 6.47. Viewray has a fifty-two week low of $4.86 and a fifty-two week high of $13.21. The stock has a market cap of $798.39 million, a price-to-earnings ratio of -8.01 and a beta of 1.30.
Several equities analysts have weighed in on the company. Cantor Fitzgerald reaffirmed a “buy” rating and set a $13.00 target price on shares of Viewray in a research note on Thursday, December 6th. ValuEngine cut Viewray from a “buy” rating to a “hold” rating in a research note on Tuesday, January 29th. Morgan Stanley assumed coverage on Viewray in a research note on Tuesday, December 11th. They set an “equal weight” rating and a $7.00 target price on the stock. BidaskClub raised Viewray from a “sell” rating to a “hold” rating in a research note on Tuesday, January 1st. Finally, Northland Securities reaffirmed a “buy” rating and set a $20.00 target price on shares of Viewray in a research note on Thursday, December 6th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Viewray currently has an average rating of “Buy” and a consensus target price of $12.69.
WARNING: This article was first posted by WKRB News and is owned by of WKRB News. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.wkrb13.com/2019/03/15/viewray-vray-announces-quarterly-earnings-results.html.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Featured Article: What is a Lock-Up Period?
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.